Treatment of Schizophrenia with Aripiprazole. A one year open-label study examining an ultraslow switchover regime to minimise relapse and withdrawal symptoms.
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Adverse reactions; Therapeutic Use
- 29 Jun 2016 New trial record